Condensed Consolidated Statements of Operations (Unaudited) - USD ($) |
3 Months Ended | 6 Months Ended | 12 Months Ended | ||||||
|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2023 |
Jun. 30, 2022 |
Mar. 31, 2022 |
Jun. 30, 2021 |
Jun. 30, 2022 |
Jun. 30, 2021 |
Dec. 30, 2020 |
Dec. 31, 2022 |
Dec. 31, 2021 |
|
| Operating loss | $ (5,824,197) | $ (2,687,968) | $ (18,379,329) | $ (6,519,918) | |||||
| Other (income) expense: | |||||||||
| Foreign currency transaction (gain) loss | (9,884) | 9,848 | |||||||
| Other (income) expense: | |||||||||
| Other expense, net | 1,152,381 | 4,212 | (293,862) | (1,601,568) | |||||
| Loss on extinguishment of debt | 9,484,113 | ||||||||
| Interest expense, net | 976,422 | 801,974 | 3,714,017 | 725,166 | |||||
| Total other (income) expense, net | 4,355,823 | 816,034 | 9,881,242 | 8,607,711 | |||||
| Change in fair value of warrant liabilities | 2,236,904 | 6,461,087 | |||||||
| Income taxes | |||||||||
| Net income (loss) | $ (10,180,020) | $ (3,356,956) | $ (3,504,002) | $ (1,074,911) | $ (28,260,571) | $ (15,127,629) | |||
| Basic weighted average shares outstanding (in Shares) | 39,765,361 | 9,669,217 | 18,982,139 | 9,637,962 | |||||
| Basic earnings (loss) per share (in Dollars per share) | $ (0.26) | $ (0.36) | $ (1.75) | $ (1.57) | |||||
| Revenue: | |||||||||
| Total revenue | $ 2,820,780 | $ 2,235,965 | $ 11,434,959 | $ 8,591,540 | |||||
| Costs and expenses: | |||||||||
| Cost of revenue (exclusive of items shown separately below) | 2,932,267 | 1,899,161 | 11,863,862 | 6,850,248 | |||||
| Depreciation | 273,099 | 111,319 | 516,949 | 365,097 | |||||
| Research and development | 226,967 | 1,267,412 | 2,376,912 | 3,533,713 | |||||
| General and administrative | 5,212,644 | 1,646,041 | 15,056,565 | 4,362,400 | |||||
| Total costs and expenses | 8,644,977 | 4,923,933 | 29,814,288 | 15,111,458 | |||||
| Service | |||||||||
| Revenue: | |||||||||
| Revenue | $ 2,820,780 | 2,235,965 | 11,210,559 | 7,854,068 | |||||
| Product | |||||||||
| Revenue: | |||||||||
| Revenue | 242,637 | ||||||||
| Service – related party | |||||||||
| Revenue: | |||||||||
| Related party-Revenue | 224,400 | 332,767 | |||||||
| Product – related party | |||||||||
| Revenue: | |||||||||
| Related party-Revenue | 162,068 | ||||||||
| CleanTech Acquisition Corp | |||||||||
| Operating costs | 1,446,459 | $ 1,905,106 | $ 1,000 | 1,201,383 | |||||
| Franchise tax expense | 76,033 | 96,761 | 97,200 | ||||||
| Operating loss | (1,522,492) | (2,001,867) | (1,000) | (1,298,583) | |||||
| Other (income) expense: | |||||||||
| Transaction costs allocated to warrant liabilities | (155,037) | ||||||||
| Net gain on investments held in Trust Account | 235,270 | 252,815 | 5,428 | ||||||
| Change in fair value of warrant liabilities | 503,750 | 2,917,250 | 1,077,750 | ||||||
| Income (loss) before income taxes | (783,472) | 1,168,198 | |||||||
| Income taxes | (12,359) | (12,359) | |||||||
| Change in fair value of over-allotment option liability | (225,000) | ||||||||
| Net income (loss) | $ (795,831) | $ 1,951,670 | $ 1,155,839 | $ (1,000) | $ (595,442) | ||||
| Basic weighted average shares outstanding (in Shares) | 21,562,500 | 3,750,000 | 21,562,500 | 3,750,000 | 3,750,000 | 11,781,678 | |||
| Basic earnings (loss) per share (in Dollars per share) | $ (0.04) | $ 0 | $ 0.05 | $ 0 | $ 0 | $ (0.05) | |||
| X | ||||||||||
- Definition The amount of gain on change in fair value of warrant liabilities. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Related party-revenue. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of warrant issuance costs. No definition available.
|
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Total costs of sales and operating expenses for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition For each line item in the statement of financial position, the amounts of gains and losses from fair value changes included in earnings. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Aggregate costs incurred that are directly related to activities, including but not limited to, generating franchise revenues from franchisor owned outlets and franchised outlets. No definition available.
|
| X | ||||||||||
- Definition Amount of realized and unrealized gain (loss) on investment. Reference 1: http://www.xbrl.org/2003/role/recommendedDisclosureRef
|
| X | ||||||||||
- Definition Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The net amount of operating interest income (expense). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense. No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|